2019 Emerging Issues in Oncology Webinar Series
The 2019 BCOP Webinar Series is an educational program designed for the practicing advanced level Board Certified Oncology Pharmacist. Covering key abstracts and emerging issues from national hematology/oncology meetings. Each webinar is worth 1 hour BCOP and/or 1 hour ACPE credit.Each webinar will:
- Review key findings from clinical and translational research based on data presented at national hematology/oncology meetings.
- Explore late-breaking topics and timely data from across the spectrum of oncology and oncology pharmacy.
- Examine the most relevant data for oncology pharmacists, and discuss the impact on practice.
Webinar 1 – Updates from the American Society of Hematology (ASH) Annual Meeting (product is no longer available)
Webinar 2 – Updates from the American Society for Blood and Marrow Transplantation (ASBMT) Annual Meeting (product is no longer available)
Webinar 3 – Updates from American Society of Clinical Oncology (ASCO) Hem Focus (Release date: August 29, 2019)
Webinar 4 – Updates from American Society of Clinical Oncology (ASCO) Solid Tumors (Release date: September 5, 2019)
Webinar 5 – Updates from Infections Disease Society of America (IDSA) (Release date: December 20, 2019)
Each webinar will include a live presentation from the faculty presenting their topic (the learner will also have access to the recording after the live presentation), a pre-test and BCOP post-test.
You may choose to complete all or select webinars, receiving BCOP credit for each completed webinar which achieves a passing score.
The 2019 BCOP Emerging Issues in Oncology Webinar Series is also a part of the 2019 BCOP Program Bundle. If you’ve already purchased the 2019 BCOP Program Bundle, you can access your webinars in My Education Library.
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form.
The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of Board Certified Oncology Pharmacist (BCOP) credit. A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved.
Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.
Reported Areas of Conflict: Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.